Group One Trading, L.P. Absci Corp Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$1.28 - $2.41 $3,651 - $6,875	2,853 Added 42.29%	9,599 $12,000
Q2 2023 Aug 09, 2023	BUY	$1.17 - $2.03 $7,892 - $13,694	6,746 New	6,746 $10,000
Q4 2022 Feb 09, 2023	BUY	$2.0 - $3.58 $3,140 - $5,620	1,570 New	1,570 $3,000
Q2 2022 Aug 11, 2022	BUY	$3.13 - $8.83 $6,886 - $19,426	2,200 New	2,200 $7,000

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $278M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.